(19)
(11) EP 3 003 299 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.08.2021 Bulletin 2021/33

(45) Mention of the grant of the patent:
14.07.2021 Bulletin 2021/28

(21) Application number: 14805125.3

(22) Date of filing: 14.05.2014
(51) International Patent Classification (IPC): 
C07C 57/03(2006.01)
A61P 29/00(2006.01)
 A61K 31/202(2006.01)
(86) International application number:
PCT/US2014/037969
(87) International publication number:
WO 2014/193652 (04.12.2014 Gazette 2014/49)

(54)

NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS

NEUARTIGE N-3-IMMUNORESOLVENTEN: STRUKTUREN UND AKTIONEN

NOUVEAUX IMMUNORÉSOLVANTS N-3: STRUCTURES ET ACTIONS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.05.2013 US 201361829064 P

(43) Date of publication of application:
13.04.2016 Bulletin 2016/15

(60) Divisional application:
21177568.9

(73) Proprietor: The Brigham and Women's Hospital, Inc.
Boston, MA 02115 (US)

(72) Inventors:
  • SERHAN, Charles N.
    Needham, Massachusetts 02492 (US)
  • DALLI, Jesmond
    Brookline, Massachusetts 02446 (US)

(74) Representative: Johnson, Stephen William et al
Venner Shipley LLP Byron House Cambridge Business Park Cowley Road
Cambridge CB4 0WZ
Cambridge CB4 0WZ (GB)


(56) References cited: : 
EP-B1- 2 344 441
WO-A2-2008/103753
WO-A2-2013/170006
US-A1- 2008 161 274
US-A1- 2011 178 047
 WO-A2-2006/055965
WO-A2-2012/135032
JP-A- 2011 190 184
US-A1- 2009 118 243
   
  • DALLI ET AL.: 'Novel n-3 Immunoresolvents: Structures and Actions.' SCIENTIFIC REPORTS vol. 3, no. 1940, 01 June 2013, pages 1 - 38, XP055297582 Retrieved from the Internet: <URL:http://www.researchgate.net/publicatio n/237056925_Novel_n-3_Immunoresolvents_Stru ctures_ and_Actions> [retrieved on 2014-11-06]
  • "Oxford Dictionaries", , Retrieved from the Internet: URL:https://en.oxforddictionaries.com/defi nition/and%2For [retrieved on 2019-02-04]
  • Greene & Wuts: "Protecting Groups in Organic Synthesis", 1991, John Wiley & Sons
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).